Literature DB >> 1518964

Collagenolytic cathepsin B and L activity in experimental fibrotic liver and human liver.

H Yamamoto1, Y Murawaki, H Kawasaki.   

Abstract

To clarify the role of individual collagenolytic cathepsin in hepatic collagen degradation, cathepsin B and L activities were determined in normal and CCl4-induced fibrotic liver, together with non-collagenolytic cathepsin H. Cathepsin B and L activities increased 1.9- and 2.0- fold, respectively, in the fibrotic liver as compared with the normal liver, and were significantly correlated with hepatic hydroxyproline levels. By contrast, cathepsin H activity was not altered in fibrotic rats. Similar results were also obtained from autopsied human livers. These results suggest that cathepsin B and L are similarly induced by hepatic collagen levels and are implicated in degrading collagens, especially soluble collagen.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1518964

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  4 in total

1.  Cathepsin B deficiency ameliorates liver lipid deposition, inflammatory cell infiltration, and fibrosis after diet-induced nonalcoholic steatohepatitis.

Authors:  Wenqian Fang; Zhiyong Deng; Feriel Benadjaoud; Chongzhe Yang; Guo-Ping Shi
Journal:  Transl Res       Date:  2020-05-11       Impact factor: 7.012

2.  Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential.

Authors:  Anna Moles; Núria Tarrats; José C Fernández-Checa; Montserrat Marí
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

3.  Cathepsin L and B as Potential Markers for Liver Fibrosis: Insights From Patients and Experimental Models.

Authors:  Mansi Manchanda; Prasenjit Das; Gaurav P S Gahlot; Ratnakar Singh; Elke Roeb; Martin Roderfeld; Siddhartha Datta Gupta; Anoop Saraya; R M Pandey; Shyam S Chauhan
Journal:  Clin Transl Gastroenterol       Date:  2017-06-15       Impact factor: 4.488

4.  Limited applicability of cathepsin D for the diagnosis and monitoring of non-alcoholic steatohepatitis.

Authors:  Sivesh K Kamarajah; Stanley Khoo; Wah-Kheong Chan; Pavai Sthaneshwar; Nik Raihan Nik Mustapha; Sanjiv Mahadeva
Journal:  JGH Open       Date:  2019-04-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.